Lurtotecan Liposome
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lurtotecan Liposome, covering 2020-04-06 to 2020-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer [Phase 2]